| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. | Director | Ordinary Shares | 78K | $803K | $10.29 | Apr 26, 2022 | Direct |
| Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 28K | Apr 26, 2022 | Direct | ||
| Praxis Precision Medicines, Inc. | Director | Stock Option (Right to Buy) | 8.57K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
| PRAX | Praxis Precision Medicines, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
| PRAX | Praxis Precision Medicines, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| TBPH | Theravance Biopharma, Inc. | Apr 26, 2022 | 2 | $0 | 4 | Apr 28, 2022 | Director |
| PRAX | Praxis Precision Medicines, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
| PRAX | Praxis Precision Medicines, Inc. | May 13, 2021 | 1 | $0 | 4 | Jul 7, 2021 | Director |